在高血压诱导的左心室重塑中增加分泌的Frizzled相关蛋白2
Mengying Cao1,2, Xueli Jiang1,2, Xiaolin Wang1,2
1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.
Reviews in cardiovascular medicine
|July 30, 2024
概括
分泌的纹相关蛋白2 (sFRP2) 在患有左心室重塑的高血压患者中升高. 这种生物标志物显示出在高血压患者中区分心脏重塑的潜力.
科学领域:
- 心血管生物学 心血管生物学
- 生物标志物发现发现
- 高血压研究 高血压研究
背景情况:
- 分泌的纹相关蛋白2 (sFRP2) 在心血管疾病中起作用.
- 在高血压 (HTN) 患者中,sFRP2在左心室 (LV) 重塑中的特定作用尚不清楚.
研究的目的:
- 为了研究血清sFRP2水平与HTN患者的LV重塑之间的关联.
- 评估sFRP2作为HTN中LV重塑的潜在诊断标志物.
主要方法:
- 与酶相关的免疫吸收试验 (ELISA) 用于测量196名HTN患者和100名对照者的血清sFRP2水平.
- 心声学评估LV重塑;接收器运行特征 (ROC) 曲线分析以确定诊断价值.
- 斯皮尔曼相关性和西部斑块/qPCR分析sFRP2表达和相关性.
主要成果:
- 血清sFRP2水平在LV重塑的HTN患者中明显高于没有的患者.
- ROC分析表明,sFRP2在HTN中对LV重塑具有显著的区分值 (AUC = 0.791).
- 超性心脏中sFRP2表达升高,并与LV尺寸和相对壁厚度 (RWT) 相相关.
结论:
- 在HTN患者的LV重塑的背景下,血清和心脏sFRP2水平升高.
- sFRP2显示出作为一种有价值的生物标志物,用于识别高血压患者的LV重塑的潜力.
- 米瑞丁治疗显示出有可能逆转增加的sFRP2表达.
更多相关视频
07:13A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
6.4K
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
16.8K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
674
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
674
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
578
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
578
01:17Hormonal Regulation of Blood Pressure
2.5K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.5K
01:22Heart Failure Drugs: Diuretics
355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K